Back
BioNTech SE 10K Form
Sell
22
BNTX
BioNTech SE
Last Price:
$91.34
Seasonality Move:
15.55%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BNTX News And Ratings
See the #1 stock for the next 7 days that we like better than BNTX
BNTX Financial Statistics
Sales & Book Value
| Annual Sales: | $3.2B |
|---|---|
| Cash Flow: | $277M |
| Price / Cash Flow: | 76.01 |
| Annual Sales: | $89.84 |
| Price / Book: | 1.02 |
Profitability
| EPS (TTM): | -5.23110 |
|---|---|
| Net Income (TTM): | $-1.3B |
| Gross Margin: | $2.5B |
| Return on Equity: | -5.93% |
| Return on Assets: | -5.16% |
BioNTech SE Earnings Forecast
Key BioNTech SE Financial Ratios
-
The Gross Profit Margin over the past 9 years for BNTX is 77.64%.
-
The Selling, General & Administrative Expenses for BNTX have been equal to 21.76% of Gross Profit Margin.
-
The Research & Development expenses have been 73.34% of Revenue.
-
The Net Earning history of BNTX is -39.59% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 4 years.
BioNTech SE Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BNTX |
| CUSIP: | 09075V |
| Website: | biontech.de |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 7.54 |
| Quick Ratio: | 7.36 |
Price-to-Earnings
| Trailing P/E Ratio: | 26.23 |
|---|---|
| Forward P/E Ratio: | 0 |
BNTX Technical Analysis vs Fundamental Analysis
Sell
22
BioNTech SE (BNTX)
is a Sell
Is BioNTech SE a Buy or a Sell?
-
BioNTech SE stock is rated a SellThe current BioNTech SE [BNTX] share price is $91.18. The Score for BNTX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.